Abstract
T-cell differentiation proceeds under the command of several signals, among which thymic hormones (TH) play a central role. A number of T-cell abnormalities have been described in rheumatoid arthritis (RA), both by marker and functional studies. One may raise the question of thymic hormone production in RA and in related immunologic diseases such as systemic lupus erythematosus (SLE). Additionally, since thymic hormones can modulate T-cell functions, one may attempt to improve the clinical status of RA patients by using pharmacological doses of the hormones independently of a preexisting abnormality of thymic hormone production.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ahmed, A., Wong, D. M., Thurman, G. B., Low, T. L. K., and Goldstein, A. I., 1979, T-lymphocyte maturation cell surface markers and immune function, induced by T-lymphocyte cell free products and thymosin polypeptides,Ann. N.Y. Acad. Sci.332: 81–94.
Amor, B., Dougados, M., Mery, C., de Gery, A., Choay, J., Dardenne, M., and Bach, J. F., 1984, Thymulin (FTS) in rheumatoid arthritis,Arthritis Rheum. 27:117–118.
Auteri, A., Laghi Pasini, F., Pasque, A. L., Bilenchi, R., and Di Perri, T., 1980a, Azione della timopoietina pentapeptide sulla formazione di rosette lifocitarie E di pazienti affetti da artrite reumatoide I.Studio in vitro, Boll. Soc. Ital. Biol. Sper. 4:308–311.
Auteri, A., Laghi Pasini, F., Pasqui, A. L., Bilenchi, R., and Di Perri, T., 1980b, Azione della timopoietina pentapeptide sulla formazione di rosette linfociatarie E di pazienti affetti da artrite reumatoide II. Studioin vivo Boll. Soc. Ital. Biol. Sper. 4:312–315.
Bach, J. F., 1982, Thymic factors and immunoregulation role in autoimmune diseases, in:Regulation of the Immune Response( D. N. Jacobs and P. L. Ogra, eds.), Karger, Basel, pp. 20–29.
Bach, J. F., 1983, Thymulin (FTS-Zn),Clin. Immunol. Allergy3: 133–157.
Bach, J. F., Dardenne, M., Papiernik, M., Barois, A., Levasseur, P., and Le Brigand, H., 1972, Evidence for a serum factor produced by the human thymus,Lancet1: 1056–1058.
Bach, J. F., Dardenne, M., and Salomon, J. C., 1973, Studies on thymus products. IV. Absence of serum “thymic activity” in adult NZB and (NZB x NZW) F! mice,Clin. Exp. Immunol.14: 247–256.
Bach, J. F., Dardenne, M., and Clot, J., 1975, Evaluation of serum thymic hormone and of circulating T cells in rheumatoid arthritis and in systemic lupus erythematosus,Rheumatology6: 242–250.
Bach, M. A., and Charreire, J., 1979, Role of a circulating thymic factor in self recognition and self tolerance,Ann. N.Y. Acad. Sci.332: 55–63.
Bach, M. A., Droz, D., Noel, L. H., Blanchard, D., Dardenne, M., and Peking, A., 1980, Effect of long- term treatment with circulating thymic factor on murine lupus,Arthritis Rheum. 23: 1351–1358.
Basch, R. S., and Goldstein, G. 1974, Induction of T-cell differentiationin vitroby thymin, a purified polypeptide hormone of the thymus,Proc. Natl. Acad. Sci. U.S.A.71: 1474–1478.
Bene, M. C., Faure, G., Bordigoni, P., Olive, S., and Duheille, J., 1982,In vitroinduction of monoclonal antibody-defined T-cell markers in lymphocytes from immunodeficient children by synthetic serum thymic factor (FTS),Clin. Exp. Immunol. 48:423–428.
Berrih, S., Savino, W., Azoulay, M., Dardenne, M., and Bach, J. F., 1984, Production of anti-thymulin (FTS) monoclonal antibodies by immunization against hyman thymic epithelial cells,J. Histochem. Cytochem.32: 432–438.
Cohen, S., Berrih, S., Dardenne, M., and Bach, J. F., 1983, Régulation in vitro de la secrétion de thymuline par les cellules épithéliales thymiques humaines.C. R. Acad. Sci. (Paris) (D)297: 63–65.
Dardenne, M., and Bach, J. F., 1975, The sheep cell rosette assay for the evaluation of thymic hormones, in:Biological Activity of Thymic Hormones, (D. van Bekkumed.), Kooyker Science, Rotterdam, pp. 235–243.
Dardenne, M., and Bach, J. F., 1977, Demonstration and characterization of a serum factor produced by activated T cells,Immunology33: 643.
Dardenne, M., Monier, J. C., Biozzi, G., and Bach, J. F., 1974, Studies on thymus products. V. Influence of genetic selection based on antibody production of thymic hormone production,Clin. Exp. Immunol.17: 339–344.
Dardenne, M., Pleau, J. M., Blouquit, J. Y., and Bach, J. F., 1980, Characterization of facteur thymique sérique (FTS) in the thymus II. Direct demonstration of the presence of FTS in thymosin fractionV. Clin. Exp. Immunol. 42: 477–482.
Dardenne, M., Pleau, J. M., Savino, W., and Bach, J. F., 1982a, Monoclonal antibody against the serum thymic factor (FTS),Immunol. Lett.48: 61–69.
Dardenne, M., Pleau, J. M., Nabarra, B., Lefrancier, P., Derrien, M., Choay, J., and Bach, J. F., 1982b, Contribution of zinc and other metals to the biological activity of the serum thymic factor,Proc. Natl. Acad. Sci. U.S.A.79: 5370–5373.
Dardenne, M. Savino, W., Gastinel, L. N., Nabarra, B., and Bach, J. F., 1983, Thymic dysfunction in the mutant diabetic (db/db) mouse,J. Immunol. 130(3): 1195–1199.
Duclos, M., Zeidler, H., Liman, W., Pichler, W. J., Rieber, P., and Peter, H. H., 1982, Characterization of blood and synovial fluid lymphocytes from patients with rheumatoid arthritis and other joint diseases by monoclonal antibodies (OKT series) and acid alpha-naphtyl esterase staining,Rheumatol. Int. 2: 75–82.
Fabris, N., 1980, Serum thymic factor determination in different human pathologies,Int. J. Immunopharmacol2: 157–160.
Faure, G., Bach, M. A., Bene, M. C., Kahn, M. F., Bach, J. F., and Gaucher, A., 1982, Etude des sous- populations lymphocytaires T au cours des rheumatismes inflammatoires chroniques,Rev. Rhum.49: 439–445.
Faure, G., Bene, M. C., Tamisier, J. N., Gaucher, A., and Duheille, J., 1984, Thymulin (FTS-Zn) inducedin vitromodulation of T cell subsets markers on lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients,Int. J. Immunopharmacol.6: 381–388.
Garaci, E., Ronchetti, R., Del Gobbio, V., Tramutoti, G., Rinaldi-Garaci, C., and Imperato, C., 1978, Decreased serum thymic activity in asthmatic children,J. Allergy Clin. Immunol.62: 357–362.
Gastinel, L. N., Dardenne, M., Pleau, J. M., and Bach, J. F., 1984, Studies on the zinc binding to the serum thymic factor,Biochim. Biophys. Acta.797: 147–155.
Goldstein, A. L., Guha, A., Zatz, M. M., Hardy, A., and White, A., 1972, Purification and biological activity of thymosin, a hormone of the thymus gland,Proc. Natl. Acad. Sci. U.S.A.69: 1800–1804.
Goldstein, A. L., Low, T. L. K., McAdoo, M., McLure, J., Thurman, G. B., Rossio, J. J., Lai, C. Y., Chang, D., Wang, S. S., Harvey, C., Ramel, A. H., and Meienhoffer, J., 1977, Thymosin αl: Isolation and sequence analysis of an immunologically active thymic polypeptide,Proc. Natl. Acad. Sci. U.S.A.74: 725–729.
Goldstein, G., 1974, Isolation of bovine thymin: A polypeptide hormone of the thymus,Nature, 247: 11–14.
Goldstein, G., 1975, The isolation of thymopoietin (thymin),Ann. N.Y. Acad. Sci.249: 177–183.
Goldstein, G., 1976, Radioimmunoassay for thymopoietin,J. Immunol.117: 690–692.
Goldstein, G., and Lau, C., 1980, Thymopoietin and immunoregulation, in:Polypeptide Hormones( R. F. Beers, Jr., and E. G. Bassett, eds.), Raven Press, New York, pp. 459–465.
Goldstein, G., Scheid, M. P., Boyse, E. A., Schlesinger, D. H., and Van Vauwe, J., 1979, A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin,Science204: 1309–1310.
Gualde, N., Rigaud, M., and Bach, J. F., 1982, Stimulation of prostaglandin synthesis by the serum factor (FTS),Cell Immunol. 70: 363–366.
Hirokawa, K., McClure, J. E., and Goldstein, A. L., (1982) Age related changes in localization of thymosin in the human thymus,Thymus4: 19–29.
Israel-Biet, D., Noël, L. H., Bach, M. A., Dardenne, M., and Bach, J. F., 1983, Reversal of the autoimmune disease of (NZB x NZW) F1 mice by cyclosporin A and thymulin (FTS-Zn), Clin. Exp. Immunol. 54:359–365.
Iwata, T., Incefy, G. S., Good, R. A., Cunningham-Rundles, S., Dardenne, M., Kapoor, N., Kirkpatrick, D., and O’Reilly, R. J., 1983, Circulating thymic hormone levels in severe combined immunodeficiency,Clin. Exp. Immunol.53: 1–9.
Jambon, B., Montagne, P., Bene, M. C., Brayes, M. P., Faure, G., and Duheille, J., 1981, Immunohistologic localization of “facteur thymique sérique (FTS)” in human thymic epithelium,J. Immunol.127: 2055–2059.
Laghi-Pasini, F., Auteri, A., Pasqui, A. L., and Di Petro, T., 1980, Immunokinetics of a single dose of thymopoietin pentapeptide,Int. J. Immunopharmacol.2 /3: 154–155.
Low, T. L. K., Thurman, G. B., Chincarini, C., McClure, J. E., Marshall, G. D., Hu, S. K., and Goldstein, A. L., 1979, Current status of thymosin research: Evidence for the existence of a family of thymic factors that control T-cell maturation,Ann. N.Y. Acad. Sci.332: 33.
McLure, J. E., Lameris, N., Wara, D. W., and Goldstein, A. L., 1981, Immunochemical studies on thymosin: Radioimmunoassay of thymosin al,J. Immunol.128: 368–375.
Monier, J. C., Dardenne, M., Pleau, J. M., Schmitt, D., Deschaux, P., and Bach, J. F., 1980, Characterization of the facteur thymique serique (FTS) in the thymus. I. Fixation of anti-FTS antibodies on thymic reticulo-epithelial cells,Clin. Exp. Immunol.42: 470–476.
Moutsopoulos, H., Fye, K. H., Sawada, S., Becker, M. J., Goldstein, A., and Talal, N., 1976,In vitroeffect of thymosin on T-lymphocyte rosette formation in rheumatic diseases,Clin. Exp. Immunol. 26:563–573.
Osheroff, P. L., 1981, The effect of thymosin on glucocorticoid receptors in lymphoid cells,Cell. Immunol.60: 376.
Pfreudschuh, M., Michel, H., Parino, G., Stock, C., Gause, A., and Hunstein, W., 1981, T-lymphocyte subpopulations in rheumatoid arthritis. II. Definition by monoclonal antibodies,Z. Rheumatol.40: 245–249.
Pleau, J. M., Dardenne, M., Blouquit, Y., and Bach, J. F., 1977, Structural study of circulating thymic factor: A peptide isolated from pig serum. II. Amino acid sequence, J. Biol. Chem. 252:8045–8047.
Pleau, J. M., Pasques, D., Bach, J. F., Gros, E., and Dray, F., 1978, Dosage radioimmunologique du facteur thymique serique (FTS), in:Radioimmunoassay and Related Procedures in Medicine, Vol. II. International Atomic Energy Agency, Vienna, pp. 505–510.
Pleau, J. M., Dardenne, M., Blanot, D., Bricas, I., and Bach, J. F., 1979, Antagonistic analogue of serum thymic factor (FTS) interacting with the FTS cellular receptor,Immunol. Lett.1: 179–182.
Pleau, J. M., Fuentes, V., Morgat, J. L., and Bach, J. F., 1980, Specific receptors for the serum thymic factor (FTS) in lymphoblastoid cultured cell lines.Proc. Natl. Acad. Sci. U.S.A.77: 2861–2865.
Rinaldi-Garaci, C., Garaci, E., DelGobbo, V., Favalli, C., Jezzi, T., and Goldstein, A. L., 1983, Modulation of endogenous prostaglandins by thymosin αl in lymphocytes,Cell. Immunol.80: 57–65.
Savino, W., Dardenne, M., Papiernik, M., and Bach, J. F., 1982, Thymic hormone containing cells, char-acterization and localization of serum thymic factor in young mouse thymus studied by monoclonal antibodies,J. Exp. Med.156: 628–634.
Savino, W., Dardenne, M., and Bach, J. F., 1983a, Thymic hormone containing cells II. Evolution of cells containing the serum thymic factor (FTS or thymulin) in normal and autoimmune mice, as revealed by anti-FTS monoclonal antibodies. Relationship with la bearing cells,Clin. Exp. Immunol.52: 1–6.
Savino, W., Dardenne, M., and Bach, J. F., 1983b, Thymic hormone containing cells. III. Evidence for a feed-back regulation of the secretion of the serum thymic factor (FTS) by thymic epithelial cells,Clin. Exp. Immunol.52: 7–12.
Schlesinger, D. H., and Goldstein, G., 1975, The amino acid sequence of thymopoietin II,Cell5: 361–366.
Schmitt, D., Monier, J. C., Dardenne, M., Pleau, J. M., and Bach, J. F., 1982, Location of FTS (facteur thymique serique) in the thymus of normal and autoimmune mice,Thymus4: 221–231.
Thrower, P. A., Doyle, D. V., Scott, J., and Huskisson, E. C., 1982, Thymopoietin in rheumatoid arthritis,Rheum. Rehabil.21: 72–77.
Thurman, G. B., Rossio, J. L., and Goldstein, A. L., 1977, Thymosin-induced enhancement of MIF production by peripheral blood lymphocytes of thymectomized guinea pigs, in:Regulatory Mechanisms in Lymphocyte Activation( D. O. Lucas, ed.), Academic Press, New York, pp. 629–631.
Trainin, N., and Small, M., 1970, Studies on some physicochemical properties of a thymus humoral factor conferring immunocompetence on lymphoid cells,J. Exp. Med.132: 885–889.
Twomey, J. J., Goldstein, G., Lewis, V. M., Bealmear, P. M., and Good, R. A., 1977, Biossay determinations of thymopoietin and thymic hormone levels in human plasma,Proc. Natl. Acad. Sci. U.S.A.74: 2541.
Twomey, J. J., Goldstein, G., Lewis, V. M., Bealmear, P. M., and Good, R. A., 1977, Biossay determinations of thymopoietin and thymic hormone levels in human plasma,Proc. Natl. Acad. Sci. U.S.A74:2541.
Veys, E. M., Hermans, P., Schindler, J., Kung, P. C., Goldstein, G., Symoens, J., and Van Wauwe, J., 1982a, Evaluation of T cell subsets with monoclonal antibodies in patients with rheumatoid arthritis,J. Rheumatol.9: 25–29.
Veys, E. M., Huskisson, E. C., Rosenthal, M., Vischer, T. L., Mielants, H., Thrower, P. A., Scott, J., Ott, H., Scheijgrond, H., and Symoens, J., 1982b, Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis,Ann. Rheum. Dis.41: 441–443.
Wetzel, R., Heyweker, H. L., Goeddel, D. V., Jhurani, P., Shapiro, J., Crea, R., Low, T. L. K., McClure, J. E., Thurman, G. B., and Goldstein, A. L., 1980, Production of biologically active N alpha desacetyl thymosin αl inEscherichia colithrough expression of a chemically synthesized gene,J. Biol. Chem.19: 6096–6104.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Publishing Corporation
About this chapter
Cite this chapter
Bach, J.F., Dardenne, M. (1985). Thymic Hormones and Rheumatoid Arthritis. In: Gupta, S., Talal, N. (eds) Immunology of Rheumatic Diseases. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2493-5_27
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2493-5_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9509-9
Online ISBN: 978-1-4613-2493-5
eBook Packages: Springer Book Archive